Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Peter C. Enzinger, M.D.

Concepts (295)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Esophageal Neoplasms45202416685.640 Why?
Stomach Neoplasms33202414813.650 Why?
Esophagogastric Junction2020243513.100 Why?
Adenocarcinoma43202463952.500 Why?
Antineoplastic Combined Chemotherapy Protocols572025118782.060 Why?
Cisplatin16202216601.020 Why?
Camptothecin1720176000.990 Why?
Fluorouracil23202416520.970 Why?
Platinum120222220.740 Why?
Receptor, erbB-25202426030.650 Why?
Carcinoma, Squamous Cell10202340580.610 Why?
Neoadjuvant Therapy10202429070.570 Why?
Gastrointestinal Neoplasms720239570.560 Why?
Leucovorin1320226430.520 Why?
Neuroendocrine Tumors820256590.520 Why?
Clinical Protocols1202114430.480 Why?
Cyclooxygenase 2 Inhibitors120163190.460 Why?
Esophagectomy520214810.430 Why?
Pancreatic Neoplasms12202454460.400 Why?
Gastrectomy320216930.400 Why?
Colonic Neoplasms8201725410.390 Why?
Antineoplastic Agents142020136760.380 Why?
Organoplatinum Compounds820194080.360 Why?
Paclitaxel8202417330.320 Why?
Aged7020251715040.300 Why?
Research Design2202162110.290 Why?
Receptor, Fibroblast Growth Factor, Type 2320242120.290 Why?
Colorectal Neoplasms14202369740.280 Why?
Aged, 80 and over412025596290.260 Why?
Middle Aged6920252234920.260 Why?
Surgery Department, Hospital120071700.250 Why?
Deoxycytidine1120248870.250 Why?
Disease-Free Survival12201768470.230 Why?
Male7720253647190.230 Why?
Carboplatin320227970.230 Why?
Humans11020257681660.220 Why?
Neoplasm Staging162021112440.220 Why?
Adult6020252236460.220 Why?
Combined Modality Therapy10202185420.220 Why?
Epirubicin32021820.220 Why?
Survival Rate132021128400.220 Why?
Female7720253971920.220 Why?
Taxoids320206670.220 Why?
Antineoplastic Agents, Phytogenic320066220.210 Why?
Neoplasm Metastasis15202449120.210 Why?
Antibodies, Monoclonal11202492630.200 Why?
Drug Administration Schedule11201648600.200 Why?
Hypoalbuminemia12023900.200 Why?
Granuloma, Foreign-Body12021410.190 Why?
Appendiceal Neoplasms120231550.180 Why?
Anus Neoplasms320123360.180 Why?
Topoisomerase I Inhibitors12000700.180 Why?
Keratins120214990.170 Why?
Barrett Esophagus120044950.170 Why?
Treatment Outcome322024653710.170 Why?
Quinazolines9201213730.160 Why?
Rectal Neoplasms3201511830.160 Why?
Colectomy120046960.160 Why?
Dacarbazine320125520.160 Why?
Lymph Node Excision2202012710.160 Why?
Claudins320241160.160 Why?
Nausea220246820.150 Why?
Interleukin-1beta1202410270.150 Why?
Liver Neoplasms6201443620.150 Why?
Neutropenia120238920.150 Why?
HSP90 Heat-Shock Proteins120204230.140 Why?
Peritoneal Neoplasms120237140.130 Why?
Maximum Tolerated Dose620128990.130 Why?
Deglutition Disorders320166400.130 Why?
Double-Blind Method52023124650.130 Why?
Vascular Endothelial Growth Factor Receptor-2120195470.130 Why?
Administration, Oral6201640300.130 Why?
Anorexia120161530.130 Why?
Quality-Adjusted Life Years1202217410.130 Why?
Fluorodeoxyglucose F182201820550.120 Why?
Carcinoma2202023320.120 Why?
Neoplasms, Second Primary1202310610.120 Why?
Survival Analysis132021101010.120 Why?
Microsatellite Instability320227260.120 Why?
Guidelines as Topic2201913970.120 Why?
Lymphatic Metastasis2202129140.120 Why?
Medical Oncology5202323460.120 Why?
Tumor Suppressor Protein p532202429540.120 Why?
Alcohol Drinking2200440450.120 Why?
Triazoles120209040.110 Why?
Radiopharmaceuticals2201827350.110 Why?
Sirolimus2201315400.110 Why?
Neoplasm Recurrence, Local4201794190.110 Why?
Antimetabolites, Antineoplastic320066460.110 Why?
Laparoscopy1200420410.100 Why?
Papillomavirus Infections1202416400.100 Why?
Indoles2201118360.100 Why?
Angiogenesis Inhibitors4201420560.100 Why?
beta Karyopherins12011460.090 Why?
Palliative Care4201736430.090 Why?
Chemotherapy, Adjuvant2202135560.090 Why?
Carcinoma, Hepatocellular3200923330.090 Why?
Vascular Endothelial Growth Factors120127480.090 Why?
Informed Consent1201710100.090 Why?
Enzyme Inhibitors1200037280.090 Why?
Clinical Trials, Phase III as Topic220248790.090 Why?
Hydroxychloroquine120144260.090 Why?
Preoperative Care2201322580.080 Why?
Treatment Failure1201626610.080 Why?
Phenylurea Compounds120135310.080 Why?
Cost-Benefit Analysis1202255360.080 Why?
Immunoconjugates120179750.080 Why?
Disease Progression72017136710.080 Why?
Kaplan-Meier Estimate6202065260.080 Why?
O(6)-Methylguanine-DNA Methyltransferase12009820.080 Why?
Quality of Life42024134900.080 Why?
Carcinoid Tumor220092250.070 Why?
Genomic Instability120127160.070 Why?
Time Factors72021402180.070 Why?
Patient Participation1201714470.070 Why?
Biliary Tract Neoplasms120091870.070 Why?
Tubulin120116950.070 Why?
Quinolines120137720.070 Why?
Follow-Up Studies52019393480.070 Why?
Patient Education as Topic1201723370.070 Why?
Oxonic Acid12006320.070 Why?
Tegafur12006400.070 Why?
Autophagy1201413490.060 Why?
Endostatins120061670.060 Why?
Digestive System Neoplasms12006820.060 Why?
Prognosis52019300100.060 Why?
Young Adult82024600660.060 Why?
Geriatric Assessment1201314220.060 Why?
TOR Serine-Threonine Kinases2201120620.060 Why?
Vinblastine120064870.060 Why?
Delivery of Health Care1202253670.060 Why?
Video-Assisted Surgery12004510.060 Why?
Melanoma1202357060.060 Why?
Recombinant Proteins3202365140.060 Why?
Pheochromocytoma120063280.050 Why?
Esophageal Fistula12003600.050 Why?
Terminally Ill120052400.050 Why?
Data Collection1201333270.050 Why?
Pyrroles1200911240.050 Why?
Retrospective Studies92023817620.050 Why?
Somatostatin120254580.050 Why?
Boronic Acids120069150.050 Why?
Cell Transformation, Neoplastic1201228460.050 Why?
Carcinoma, Neuroendocrine120063430.050 Why?
Gallbladder Neoplasms120041900.050 Why?
Radiotherapy Dosage2202129160.050 Why?
CpG Islands1200712080.050 Why?
Human papillomavirus 16120242680.050 Why?
Hypertension1202286160.050 Why?
Vascular Endothelial Growth Factor A3202235140.050 Why?
Proto-Oncogene Proteins B-raf3202320590.050 Why?
Protein Kinases1200816110.050 Why?
Quality Improvement1201738570.050 Why?
Survival120211600.050 Why?
Vomiting120246550.050 Why?
Practice Guidelines as Topic3201574540.050 Why?
Salvage Therapy1200712730.050 Why?
Pyrazines1200612050.040 Why?
Tumor Microenvironment2202439480.040 Why?
North America1202412890.040 Why?
Albumins120235770.040 Why?
Granulocyte Colony-Stimulating Factor120236310.040 Why?
Adrenal Gland Neoplasms120067350.040 Why?
Randomized Controlled Trials as Topic32024103990.040 Why?
Pyrimidinones120233860.040 Why?
Dose-Response Relationship, Drug32009107600.040 Why?
Mitogen-Activated Protein Kinase Kinases120236370.040 Why?
Multicenter Studies as Topic1202417370.040 Why?
Antibodies, Bispecific120222040.040 Why?
Edema120237650.040 Why?
Nutrition Surveys1200517380.040 Why?
Clinical Trials, Phase II as Topic120006400.040 Why?
Prospective Studies32018549260.040 Why?
Molecular Diagnostic Techniques120236200.040 Why?
DNA, Neoplasm1202317440.040 Why?
Isotretinoin119991340.040 Why?
Infusions, Intravenous3200922300.040 Why?
Pyridones120238190.040 Why?
DNA, Viral1202422040.040 Why?
Pamphlets12017710.030 Why?
Protein-Tyrosine Kinases1200624330.030 Why?
Positron-Emission Tomography2201266690.030 Why?
Clinical Trials as Topic2200480540.030 Why?
Leukocytes, Mononuclear1202318540.030 Why?
Risk Assessment52021243150.030 Why?
Gastroesophageal Reflux120038360.030 Why?
In Situ Hybridization, Fluorescence1202225210.030 Why?
Gene Amplification1202010950.030 Why?
Retreatment120175980.030 Why?
ras Proteins2201410580.030 Why?
Oxaloacetates1201450.030 Why?
Interferon-alpha119999100.030 Why?
Risk Factors52021749440.030 Why?
China1202023950.030 Why?
Neoplasms22017223710.030 Why?
Antineoplastic Agents, Alkylating220096140.030 Why?
Drug Resistance, Neoplasm3202053410.030 Why?
Feeding Behavior1200532050.030 Why?
Carcinoma, Pancreatic Ductal1202417570.030 Why?
Karnofsky Performance Status120131620.030 Why?
DNA Methylation1200744280.030 Why?
Genomics2202359260.030 Why?
Video Recording120179760.020 Why?
High-Throughput Nucleotide Sequencing1202436710.020 Why?
United States42020730390.020 Why?
Blood Loss, Surgical120156420.020 Why?
Clinical Competence1200748580.020 Why?
GTP Phosphohydrolases120145250.020 Why?
Mutation32024302380.020 Why?
Patient Compliance1202126970.020 Why?
CD8-Positive T-Lymphocytes1202446480.020 Why?
Thalidomide220068860.020 Why?
Protein Kinase Inhibitors2202357030.020 Why?
Perioperative Care1201810430.020 Why?
Transcription, Genetic1202476080.020 Why?
Core Binding Factor Alpha 2 Subunit120123550.020 Why?
Microtubule-Associated Proteins1201410740.020 Why?
Oncogene Protein v-akt120081300.020 Why?
Medicare1200768090.020 Why?
Drug Therapy, Combination1199863160.020 Why?
Proto-Oncogene Proteins2201445280.020 Why?
Length of Stay1202164980.020 Why?
Chemokine CXCL12120094570.020 Why?
Smoking1200390920.020 Why?
Molecular Targeted Therapy1201828300.020 Why?
Demography1201116410.020 Why?
Digestive System Surgical Procedures120115830.020 Why?
Carcinoma, Islet Cell12006210.020 Why?
Proto-Oncogene Proteins p21(ras)1201417670.020 Why?
Upper Gastrointestinal Tract12006460.020 Why?
Lymphocytes1201426140.020 Why?
Disease Management1201725360.020 Why?
Tocopherols12005440.020 Why?
Chromosome Aberrations1201217780.020 Why?
Incidence12003215380.020 Why?
Cluster Analysis1201227320.020 Why?
Self Administration120063860.020 Why?
Injections, Subcutaneous120066870.010 Why?
Radiotherapy1201115020.010 Why?
Cyclin-Dependent Kinase Inhibitor p27120053170.010 Why?
Biopsy, Needle1201016220.010 Why?
Gene Deletion1201226750.010 Why?
Mice, Inbred C57BL12023223790.010 Why?
Cyclin-Dependent Kinase Inhibitor p21120053790.010 Why?
Continuity of Patient Care1201110780.010 Why?
Pilot Projects1201887410.010 Why?
Age Factors12021184120.010 Why?
Gene Expression Regulation, Neoplastic1202086470.010 Why?
Feasibility Studies1201553150.010 Why?
Confidence Intervals1200929230.010 Why?
Piperidines1201216670.010 Why?
Massachusetts2200788900.010 Why?
DNA Copy Number Variations1201220480.010 Why?
Patient Selection1201542600.010 Why?
Patient Readmission1201732880.010 Why?
Animals320231692460.010 Why?
Carotenoids120056200.010 Why?
Nutrition Assessment120057400.010 Why?
Mice22023820290.010 Why?
Radiography1201269830.010 Why?
Injections, Intravenous1200313770.010 Why?
Proteasome Endopeptidase Complex1200613190.010 Why?
Drug Combinations1200620890.010 Why?
Databases, Factual1201580800.010 Why?
Guideline Adherence1201022350.010 Why?
Doxorubicin1200622340.010 Why?
Phosphatidylinositol 3-Kinases1200828850.010 Why?
Interleukin-61200932280.010 Why?
Recurrence1201185090.010 Why?
Vitamin D1201233110.010 Why?
Decision Making1201339530.010 Why?
Tomography, X-Ray Computed22012207600.010 Why?
Early Detection of Cancer1201332390.010 Why?
Postoperative Complications12021158320.010 Why?
Breast Neoplasms12005212060.010 Why?
Fatty Acids1200518120.010 Why?
Membrane Proteins1201478760.010 Why?
DNA Mutational Analysis1200541200.010 Why?
Signal Transduction22011236450.010 Why?
Proto-Oncogene Proteins c-akt1200524570.010 Why?
Electronic Health Records1201448870.010 Why?
Stem Cells1200935370.010 Why?
Cell Line, Tumor12012171400.010 Why?
Tumor Suppressor Proteins1200528100.010 Why?
Proportional Hazards Models12009125430.010 Why?
Base Sequence12005124210.010 Why?
Cell Cycle Proteins1200534450.010 Why?
Hospitalization12014108400.010 Why?
Multivariate Analysis12005120770.010 Why?
Immunohistochemistry12005110950.010 Why?
Algorithms12011141640.010 Why?
Genetic Predisposition to Disease12012180650.010 Why?
Adolescent12019891690.010 Why?
Reproducibility of Results12005202270.000 Why?
Magnetic Resonance Imaging12009367430.000 Why?
Enzinger's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (295)
Explore
_
Co-Authors (122)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.